Mounjaro Prices in the UK: What Affects the Cost

The cost of Mounjaro (tirzepatide) in the UK depends mainly on whether you are treated on the NHS or privately, which dose you are prescribed, and what a private provider includes in its price. On the NHS, you pay only the standard prescription charge in England (or nothing in Scotland, Wales and Northern Ireland). Privately, higher strengths generally cost more, particularly since Eli Lilly raised UK list prices for private supply on 1 September 2025, and providers differ in how they bundle consultations, needles, delivery and ongoing support. We do not quote prices in this guide because they change often; current ranges are on our Mounjaro prices page.

This guide explains what drives the cost, what changed in 2025, which extras to look out for and how to compare providers fairly. For an overview of the medicine itself, see our complete guide to Mounjaro in the UK or the Mounjaro hub.

Why we do not quote prices

Prices for prescription-only weight-loss medicines change frequently, vary between providers and depend on dose. Printing figures in an article risks them being out of date within weeks. UK rules also restrict the promotion of prescription-only medicines to the public. Instead, this guide explains how pricing works so that you can make sense of the figures you see. Our prices hub is where we maintain a comparison of service features and pricing structures.

NHS vs private: two very different cost models

On the NHS

NICE recommended tirzepatide for weight management in technology appraisal TA1026 in December 2024. Since June 2025, NHS England has been rolling it out in stages through primary care, starting with people with the highest BMI and several weight-related conditions. See Mounjaro on the NHS for the current eligibility criteria.

If you are prescribed it on the NHS:

• in England, you pay the standard NHS prescription charge per item unless you are exempt (for example, because of age, certain medical conditions or low income); a prescription prepayment certificate can reduce costs if you need regular prescriptions
• in Scotland, Wales and Northern Ireland, NHS prescriptions are free

The NHS pays for the medicine itself under commercial arrangements with the manufacturer, which are confidential. When the private list price rose in September 2025, Community Pharmacy England and the Department of Health and Social Care confirmed reimbursement arrangements so that community pharmacies could continue dispensing NHS prescriptions. NHS patients were not asked to pay more. The NHS website lists the current prescription charge and exemptions.

Privately

Private treatment is available from online pharmacies, high-street pharmacies with online services and private clinics. Each sets its own prices. Many people use private treatment because they meet the MHRA licence criteria (a BMI of 30 or more, or 27 or more with a weight-related condition) but not the narrower, phased NHS criteria. See Private vs NHS weight loss treatment.

What makes up a private price?

A private price typically reflects several components:

When comparing, the most useful question is: what is the total monthly cost at my current dose, including everything I need?

Factor 1: the dose strength

Mounjaro KwikPens come in six strengths, from 2.5mg to 15mg, and each pen holds four weekly doses. Since September 2025, higher strengths have carried higher list prices, so a month at 15mg usually costs more privately than a month at 5mg.

Providers handle this in different ways:

• Tiered pricing: a different price for each strength
• Banded pricing: one price for a group of doses
• Flat pricing: the same price across all strengths

Because the dose normally rises every four weeks or more during the first months, your monthly cost may increase until you reach your maintenance dose. See Mounjaro doses explained.

Why the "right" dose matters for cost

The UK product information lists 5mg, 10mg and 15mg as maintenance doses, and in SURMOUNT-1 the additional average weight loss from 10mg to 15mg was smaller than from 5mg to 10mg. If you are doing well on a lower dose, your prescriber may not recommend increasing. That decision should be clinical, but it is reasonable to discuss cost openly with your prescriber.

Factor 2: the September 2025 list-price change

On 15 August 2025, Eli Lilly confirmed that UK list prices for Mounjaro KwikPens supplied privately would rise from 1 September 2025. The largest proportional increases applied to the higher strengths. Lilly said the change was intended to address pricing inconsistencies compared with other developed countries, noting that the UK launch price had been set well below the European average.

What happened next varied:

• Some providers raised prices immediately; others held prices temporarily or phased increases.
• Lilly offered pharmacies commercial arrangements that could reduce the cost of supply, which some providers used to soften increases.
• There were reports of people stocking up on several months' supply before the change, which raised concerns about storage and clinical oversight.

For the full story, see The 2025 Mounjaro price rise.

Factor 3: consultation and clinical support

Prescription-only medicines must be prescribed after a proper clinical assessment. Providers differ in:

• whether an initial consultation is free, charged separately or included in the first supply
• how often they review progress and who carries out reviews
• how easy it is to contact a pharmacist or prescriber about side effects
• whether they offer dietary or behavioural support

Lower prices sometimes reflect lighter-touch support. That may suit some people, but ongoing clinical oversight is an important part of safe treatment. See The online weight loss consultation.

Factor 4: needles, sharps bins and delivery

• Pen needles: the Mounjaro KwikPen pack does not include needles. You need a new needle for every injection, plus priming.
• Sharps bin: used needles should go into a sharps container. Ask how disposal works in your area.
• Delivery: Mounjaro should be stored in a fridge before first use, so providers use temperature-protected packaging. Faster or named-day delivery may cost more.

Factor 5: subscriptions, minimum terms and flexibility

Many providers use subscriptions. Before signing up, it is worth checking:

• whether there is a minimum term or cancellation fee
• how dose changes affect the subscription
• whether you can pause, for example around surgery or travel
• how price changes are communicated and when they take effect
• what happens if you switch to another provider mid-treatment

Introductory offers can make the first month look very different from later months. Looking at the expected cost over six or twelve months gives a more realistic view. See The hidden costs of private weight loss treatment and Switching providers mid-treatment.

How costs typically change over the first months

Because treatment starts at 2.5mg and usually increases every four weeks or more, the private cost of the first few months is rarely flat. The table shows the general pattern for someone stepping up at the fastest licensed pace. It describes the direction of cost, not actual figures.

Not everyone follows this path. Some people stay on 5mg or 10mg, and some spend longer at each step. Asking a provider to show how their price changes at each strength makes it easier to budget.

Questions to ask a provider about cost

Before starting private treatment, it can help to ask:

• What is the total monthly cost at each strength, including consultations, needles and delivery?
• Is the price the same if I stay on a dose for longer than four weeks?
• Are there fees for changing dose, pausing or cancelling?
• How much notice do you give before a price change, and does it apply to existing patients?
• What support is included between supplies, and is it charged separately?
• If I need to transfer to another provider or to the NHS, what information will you share and is there any charge?

Managing costs safely

Cost pressures can lead people to take risks with their treatment. Approaches that are consistent with safe care include:

• discussing your dose openly with your prescriber, as a lower maintenance dose may be clinically appropriate for some people
• checking whether you might be eligible on the NHS, now or as later cohorts open
• using a prescription prepayment certificate in England if you are treated on the NHS and need several regular prescriptions
• planning any stop or step-down with your prescriber rather than stopping suddenly

Approaches that carry real risks include splitting or stretching pens, extending the gap between doses without advice, stockpiling pens that may not be stored correctly, and using unregulated sellers.

Thinking about the longer-term cost

Weight regain is common after stopping tirzepatide. In SURMOUNT-4, people switched to placebo after 36 weeks regained a substantial share of their lost weight over the following year. This means private treatment can become a long-term cost, not a short course. Important questions include:

• How long am I likely to take it?
• What will my maintenance dose probably be, and what does it cost?
• What is my plan if I need to stop for financial reasons?
• Could I become eligible for NHS treatment as the rollout widens?

Stopping suddenly for cost reasons without a plan can lead to regain. If cost is becoming a problem, talk to your prescriber about the safest way forward. See The long-term cost of GLP-1 treatment and our Mounjaro maintenance guide.

Is a higher price a sign of better care?

Not necessarily. The medicine inside a genuine Mounjaro KwikPen is the same whichever regulated pharmacy supplies it. Differences in price usually reflect the service around it. A higher price may include more frequent clinical reviews, dietitian or coaching support, faster delivery or easier access to a prescriber. A lower price may reflect lighter-touch support or a different business model.

What matters most for safety is not the price but whether the provider:

• is properly registered and carries out a genuine clinical assessment
• verifies your identity and weight
• asks about your medical history and other medicines
• monitors your progress and side effects over time
• gives you a clear route to clinical advice

Comparing these features alongside the total monthly cost gives a more meaningful comparison than price alone. Our compare pages set regulated providers side by side on these points.

Does where you live affect the cost?

For private treatment, prices are generally set nationally by each provider, so where you live in the UK usually makes little difference to the medicine price, although delivery options may vary. For NHS treatment, where you live matters more: prescriptions are free in Scotland, Wales and Northern Ireland, while the standard charge applies in England unless you are exempt. Access timescales under the NHS rollout may also differ between areas and between the four nations.

How Mounjaro cost compares with other options

The relative cost of Mounjaro, Wegovy (semaglutide) and other treatments varies by dose and provider, and has shifted since 2025. Newer oral options, including the Wegovy tablet and Foundayo (orforglipron), were authorised by the MHRA in 2026 and are available privately at the time of writing; their costs and NHS status depend on NICE appraisals. Cost is only one factor alongside effectiveness, side effects, other health conditions and preference. See Mounjaro vs Wegovy and How weight loss injection pricing works.

Warning signs: when a low price is a red flag

The MHRA has repeatedly warned about fake and unlicensed weight-loss injections sold online. Warning signs include:

• no consultation, or only a brief tick-box form with no prescriber involvement
• no request to verify your identity or weight
• sales through social media, messaging apps or beauty salons
• products described as "research peptides", vials or powders to mix
• no GPhC registration number, or a registration that does not match
• prices dramatically below those of regulated pharmacies

Counterfeit products may contain the wrong dose, no active ingredient or harmful substances. See Fake and unlicensed weight loss jabs and Getting weight loss injections online safely.

How to compare providers fairly

A simple checklist:

1. Check registration with the GPhC, and with the CQC or equivalent regulator where a prescribing service is involved.
2. Ask for the total monthly cost at each dose, including needles, delivery and consultations.
3. Understand how pricing changes as your dose increases.
4. Check subscription terms, cancellation and pause options.
5. Find out how to contact a clinician and how often reviews happen.
6. Consider the quality of safety checks, not just the price.

Our providers page compares regulated services on these points, and you can see side-by-side comparisons on our compare pages.

When to speak to a professional

Cost questions can lead to decisions that affect your health. Talk to your prescriber, GP or pharmacist:

• before stopping, pausing or reducing your dose for cost reasons
• if you are considering switching medicine or provider
• if you are thinking about getting several months' supply at once, to check storage and safety
• if you have been offered Mounjaro from a source you are unsure about
• to ask whether you might be eligible for NHS treatment

Seek urgent medical help (NHS 111, or 999 in an emergency) if, while taking Mounjaro, you have:

• severe, persistent abdominal pain, which may spread to the back, with or without vomiting
• signs of a severe allergic reaction, such as swelling of the face or throat, or difficulty breathing
• symptoms after using a product you suspect may be fake, such as unexpected severe reactions

You can report suspected fake medicines and side effects to the MHRA through the Yellow Card scheme.